RxDoctor Payments Data

Keely Staten, PA

Physician Assistant · Columbus, MSNPI 1649758004

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.1% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,143 and has fallen 53.9% since, to $526 in 2025.

$3,050in general payments, 2019–2025

Across 102 payments — averaging $29.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$697
  • AbbVie$466
  • E.r. Squibb & Sons, L.L.C.$364
  • Regeneron Healthcare Solutions, Inc.$359
  • Lilly USA, LLC$230
  • Sun Pharmaceutical Industries Inc.$216
  • plus $718 from 12 others

What the payments were for

  • Food & beverage$2,87094%
  • Education$1806%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,050 in reported general payments places this provider in the 80th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$254,783
Medicare patients
766
Services billed
4,551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab14$53,121
Clobetasol Propionate122$4,926
Ketoconazole142$2,955
Fluorouracil31$2,705
Metronidazole45$2,133
Triamcinolone Acetonide226$1,992
Azelaic Acid12$1,925
Doxycycline Hyclate90$1,589
Gentamicin Sulfate16$657
Clindamycin Phosphate14$654
Mupirocin105$576
Desonide12$546
Cephalexin72$318
Hydrocortisone14$103
ValacyclovirValacyclovir Hcl12$80

Paid to pharmacies, not to this prescriber.

Other physician assistant in Columbus

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →